Pyc Therapeutics Limited has released a press release.
ADOA Program Update
Earlier from Pyc Therapeutics
- PKD - Initiation of Multiple Dose Clinical Trial
- Presentation of Ophthalmology Clinical Trial Data at ARVO
- ADOA Program - SRC Approve Progression to Multi-Dose Study
- Completion of Retail Entitlement Offer
